SXTC logo

China SXT Pharmaceuticals, Inc. Stock Price

NasdaqCM:SXTC Community·US$159.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SXTC Share Price Performance

US$1.37
-2.52 (-64.75%)
US$1.37
-2.52 (-64.75%)
Price US$1.37

SXTC Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

China SXT Pharmaceuticals, Inc. Key Details

US$1.7m

Revenue

US$1.4m

Cost of Revenue

US$367.4k

Gross Profit

US$3.7m

Other Expenses

-US$3.3m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
-0.028
21.11%
-189.77%
5.2%
View Full Analysis

About SXTC

Founded
2005
Employees
75
CEO
Feng Zhou
WebsiteView website
www.sxtchina.com

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Recent SXTC News & Updates

Recent updates

No updates